North America Pigmentation Disorder Treatment Market Size, Share & Industry Trends Analysis Report By Type, By Treatment, By Distribution Channel, By Country and Growth Forecast, 2023

List of Tables

The North America Pigmentation Disorder Treatment Market would witness market growth of 4.2% CAGR during the forecast period (2023-2030).

The main factor promoting the development of the market is the rise in the number of people suffering from pigmentation disorders. Numerous nations have a large number of pigmentation disorder patients who need the development of effective pigmentation disorder treatments. In addition, rising demand for cutting-edge treatments for pigmentation disorders and increased government spending on the pharmaceutical and biotechnology industries in developing countries are predicted to positively impact the market. Furthermore, the market is anticipated to grow during the forecast period due to boosted awareness about pigmentation disorders.

Increasing emphasis on developing safe and effective pigmentation disorder treatments is one of the main trends in the market. Due to the prevalence of pigmentation disorders and the rise in demand for novel treatments, market participants emphasize developing and launching safe and effective treatments. This is anticipated to persist throughout the forecast period, driving market expansion.

North America experiences significant sun exposure, especially in regions with high ultraviolet (UV) radiation levels. Prolonged and unprotected sun exposure can cause various pigmentation disorders, including solar lentigines and melasma. The aging population in North America is growing, and many pigmentation disorders are more common with age. Age-related skin changes, such as solar lentigines and actinic keratosis, contribute to the prevalence of pigmentation disorders. North America is ethnically diverse, and individuals with skin of colour are susceptible to specific pigmentation disorders, such as melasma, post-inflammatory hyperpigmentation (PIH), and vitiligo. These conditions can affect a significant portion of the population. Thus, the increase in the prevalence of pigmentation disorder conditions in North America has been a notable trend in recent years, which is beneficial for the growth of the market.

The US market dominated the North America Pigmentation Disorder Treatment Market, By Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $315.2 million by 2030. The Canada market is experiencing a CAGR of 6.5% during (2023 - 2030). Additionally, The Mexico market would exhibit a CAGR of 5.6% during (2023 - 2030).

Based on Type, the market is segmented into Vitiligo, Melasma, and Others. Based on Treatment, the market is segmented into Corticosteroids, Calcineurin Inhibitor, and Others. Based on Distribution Channel, the market is segmented into Drug Store & Retail Pharmacies, Hospital Pharmacies, & Online Pharmacies. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.

The market research report covers the analysis of key stakeholders of the market. Key companies profiled in the report include Bausch Health Companies Inc, Glenmark Pharmaceuticals Limited, Obagi Cosmeceuticals LLC, AbbVie, Inc., Dermavant Sciences, Inc. (Roivant Sciences Ltd.), Incyte Corporation, Dr. Reddy's Laboratories Ltd., Galderma S.A., Viatris, Inc. (Mylan N.V.), and Pfizer, Inc.

Scope of the Study

Market Segments covered in the Report:

By Type

Vitiligo
Melasma
Others

By Treatment

Corticosteroids
Calcineurin Inhibitor
Others

By Distribution Channel

Drug Store & Retail Pharmacies
Hospital Pharmacies
Online Pharmacies

By Country

US
Canada
Mexico
Rest of North America

Companies Profiled

Bausch Health Companies Inc
Glenmark Pharmaceuticals Limited
Obagi Cosmeceuticals LLC
AbbVie, Inc.
Dermavant Sciences, Inc. (Roivant Sciences Ltd.)
Incyte Corporation
Dr. Reddy's Laboratories Ltd.
Galderma S.A.
Viatris, Inc. (Mylan N.V.)
Pfizer, Inc.

Unique Offerings from KBV Research

Exhaustive coverage
Highest number of market tables and figures
Subscription based model available
Guaranteed best price
Assured post sales research support with 10% customization free

Chapter 1. Market Scope & Methodology

1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
- 1.4.1 North America Pigmentation Disorder Treatment Market, by Type
- 1.4.2 North America Pigmentation Disorder Treatment Market, by Treatment
- 1.4.3 North America Pigmentation Disorder Treatment Market, by Distribution Channel
- 1.4.4 North America Pigmentation Disorder Treatment Market, by Country
1.5 Methodology for the research

Chapter 2. Market at a Glance

2.1 Key Highlights

Chapter 3. Market Overview

3.1 Introduction
- 3.1.1 Overview
  - 3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
- 3.2.1 Market Drivers
- 3.2.2 Market Restraints
3.3 Porter Five Forces Analysis

Chapter 4. North America Pigmentation Disorder Treatment Market, By Type

4.1 North America Vitiligo Market, By Country
4.2 North America Melasma Market, By Country
4.3 North America Others Market, By Country

Chapter 5. North America Pigmentation Disorder Treatment Market, By Treatment

5.1 North America Corticosteroids Market, By Country
5.2 North America Calcineurin Inhibitor Market, By Country
5.3 North America Others Market, By Country

Chapter 6. North America Pigmentation Disorder Treatment Market, By Distribution Channel

6.1 North America Drug Store & Retail Pharmacies Market, By Country
6.2 North America Hospital Pharmacies Market, By Country
6.3 North America Online Pharmacies Market, By Country

Chapter 7. North America Pigmentation Disorder Treatment Market, By Country

7.1 US Pigmentation Disorder Treatment Market
- 7.1.1 US Pigmentation Disorder Treatment Market, By Type
- 7.1.2 US Pigmentation Disorder Treatment Market, By Treatment
- 7.1.3 US Pigmentation Disorder Treatment Market, By Distribution Channel
7.2 Canada Pigmentation Disorder Treatment Market
- 7.2.1 Canada Pigmentation Disorder Treatment Market, By Type
- 7.2.2 Canada Pigmentation Disorder Treatment Market, By Treatment
- 7.2.3 Canada Pigmentation Disorder Treatment Market, By Distribution Channel
7.3 Mexico Pigmentation Disorder Treatment Market
- 7.3.1 Mexico Pigmentation Disorder Treatment Market, By Type
- 7.3.2 Mexico Pigmentation Disorder Treatment Market, By Treatment
- 7.3.3 Mexico Pigmentation Disorder Treatment Market, By Distribution Channel
7.4 Rest of North America Pigmentation Disorder Treatment Market
- 7.4.1 Rest of North America Pigmentation Disorder Treatment Market, By Type
- 7.4.2 Rest of North America Pigmentation Disorder Treatment Market, By Treatment
- 7.4.3 Rest of North America Pigmentation Disorder Treatment Market, By Distribution Channel

Chapter 8. Company Profiles

8.1 Bausch Health Companies Inc
- 8.1.1 Company Overview
- 8.1.2 Financial Analysis
- 8.1.3 Segmental and Regional Analysis
- 8.1.4 Research & Development Expenses
- 8.1.5 SWOT Analysis
8.2 Glenmark Pharmaceuticals Limited
- 8.2.1 Company Overview
- 8.2.2 Financial Analysis
- 8.2.3 Regional Analysis
- 8.2.4 Research & Development Expenses
- 8.2.5 SWOT Analysis
8.3 Obagi Cosmeceuticals LLC
- 8.3.1 Company Overview
- 8.3.2 SWOT Analysis
8.4 AbbVie, Inc.
- 8.4.1 Company Overview
- 8.4.2 Financial Analysis
- 8.4.3 Regional Analysis
- 8.4.4 Research & Development Expense
8.5 Dermavant Sciences, Inc. (Roivant Sciences Ltd.)
- 8.5.1 Company Overview
- 8.5.2 Financial Analysis
- 8.5.3 Research & Development Expenses
- 8.5.4 SWOT Analysis
8.6 Incyte Corporation
- 8.6.1 Company Overview
- 8.6.2 Financial Analysis
- 8.6.3 Research & Development Expenses
  - 8.6.3.1 Acquisition and Mergers:
  - 8.6.3.2 Trials and Approvals:
- 8.6.4 SWOT Analysis
8.7 Dr. Reddy's Laboratories Ltd.
- 8.7.1 Company Overview
- 8.7.2 Financial Analysis
- 8.7.3 Segmental and Regional Analysis
- 8.7.4 Research & Development Expense
- 8.7.5 SWOT Analysis
8.8 Galderma S.A.
- 8.8.1 Company Overview
8.9 Viatris, Inc. (Mylan N.V.)
- 8.9.1 Company Overview
- 8.9.2 Financial Analysis
- 8.9.3 Segmental Analysis
- 8.9.4 Research & Development Expense
- 8.9.5 SWOT Analysis
8.10. Pfizer, Inc.
- 8.10.1 Company Overview
- 8.10.2 Financial Analysis
- 8.10.3 Regional & Segmental Analysis
- 8.10.4 Research & Development Expense
- 8.10.5 SWOT Analysis

LIST OF TABLES

TABLE 1 North America Pigmentation Disorder Treatment Market, 2019 - 2022, USD Million
TABLE 2 North America Pigmentation Disorder Treatment Market, 2023 - 2030, USD Million
TABLE 3 North America Pigmentation Disorder Treatment Market, By Type, 2019 - 2022, USD Million
TABLE 4 North America Pigmentation Disorder Treatment Market, By Type, 2023 - 2030, USD Million
TABLE 5 North America Vitiligo Market, By Country, 2019 - 2022, USD Million
TABLE 6 North America Vitiligo Market, By Country, 2023 - 2030, USD Million
TABLE 7 North America Melasma Market, By Country, 2019 - 2022, USD Million
TABLE 8 North America Melasma Market, By Country, 2023 - 2030, USD Million
TABLE 9 North America Others Market, By Country, 2019 - 2022, USD Million
TABLE 10 North America Others Market, By Country, 2023 - 2030, USD Million
TABLE 11 North America Pigmentation Disorder Treatment Market, By Treatment, 2019 - 2022, USD Million
TABLE 12 North America Pigmentation Disorder Treatment Market, By Treatment, 2023 - 2030, USD Million
TABLE 13 North America Corticosteroids Market, By Country, 2019 - 2022, USD Million
TABLE 14 North America Corticosteroids Market, By Country, 2023 - 2030, USD Million
TABLE 15 North America Calcineurin Inhibitor Market, By Country, 2019 - 2022, USD Million
TABLE 16 North America Calcineurin Inhibitor Market, By Country, 2023 - 2030, USD Million
TABLE 17 North America Others Market, By Country, 2019 - 2022, USD Million
TABLE 18 North America Others Market, By Country, 2023 - 2030, USD Million
TABLE 19 North America Pigmentation Disorder Treatment Market, By Distribution Channel, 2019 - 2022, USD Million
TABLE 20 North America Pigmentation Disorder Treatment Market, By Distribution Channel, 2023 - 2030, USD Million
TABLE 21 North America Drug Store & Retail Pharmacies Market, By Country, 2019 - 2022, USD Million
TABLE 22 North America Drug Store & Retail Pharmacies Market, By Country, 2023 - 2030, USD Million
TABLE 23 North America Hospital Pharmacies Market, By Country, 2019 - 2022, USD Million
TABLE 24 North America Hospital Pharmacies Market, By Country, 2023 - 2030, USD Million
TABLE 25 North America Online Pharmacies Market, By Country, 2019 - 2022, USD Million
TABLE 26 North America Online Pharmacies Market, By Country, 2023 - 2030, USD Million
TABLE 27 North America Pigmentation Disorder Treatment Market, By Country, 2019 - 2022, USD Million
TABLE 28 North America Pigmentation Disorder Treatment Market, By Country, 2023 - 2030, USD Million
TABLE 29 US Pigmentation Disorder Treatment Market, 2019 - 2022, USD Million
TABLE 30 US Pigmentation Disorder Treatment Market, 2023 - 2030, USD Million
TABLE 31 US Pigmentation Disorder Treatment Market, By Type, 2019 - 2022, USD Million
TABLE 32 US Pigmentation Disorder Treatment Market, By Type, 2023 - 2030, USD Million
TABLE 33 US Pigmentation Disorder Treatment Market, By Treatment, 2019 - 2022, USD Million
TABLE 34 US Pigmentation Disorder Treatment Market, By Treatment, 2023 - 2030, USD Million
TABLE 35 US Pigmentation Disorder Treatment Market, By Distribution Channel, 2019 - 2022, USD Million
TABLE 36 US Pigmentation Disorder Treatment Market, By Distribution Channel, 2023 - 2030, USD Million
TABLE 37 Canada Pigmentation Disorder Treatment Market, 2019 - 2022, USD Million
TABLE 38 Canada Pigmentation Disorder Treatment Market, 2023 - 2030, USD Million
TABLE 39 Canada Pigmentation Disorder Treatment Market, By Type, 2019 - 2022, USD Million
TABLE 40 Canada Pigmentation Disorder Treatment Market, By Type, 2023 - 2030, USD Million
TABLE 41 Canada Pigmentation Disorder Treatment Market, By Treatment, 2019 - 2022, USD Million
TABLE 42 Canada Pigmentation Disorder Treatment Market, By Treatment, 2023 - 2030, USD Million
TABLE 43 Canada Pigmentation Disorder Treatment Market, By Distribution Channel, 2019 - 2022, USD Million
TABLE 44 Canada Pigmentation Disorder Treatment Market, By Distribution Channel, 2023 - 2030, USD Million
TABLE 45 Mexico Pigmentation Disorder Treatment Market, 2019 - 2022, USD Million
TABLE 46 Mexico Pigmentation Disorder Treatment Market, 2023 - 2030, USD Million
TABLE 47 Mexico Pigmentation Disorder Treatment Market, By Type, 2019 - 2022, USD Million
TABLE 48 Mexico Pigmentation Disorder Treatment Market, By Type, 2023 - 2030, USD Million
TABLE 49 Mexico Pigmentation Disorder Treatment Market, By Treatment, 2019 - 2022, USD Million
TABLE 50 Mexico Pigmentation Disorder Treatment Market, By Treatment, 2023 - 2030, USD Million
TABLE 51 Mexico Pigmentation Disorder Treatment Market, By Distribution Channel, 2019 - 2022, USD Million
TABLE 52 Mexico Pigmentation Disorder Treatment Market, By Distribution Channel, 2023 - 2030, USD Million
TABLE 53 Rest of North America Pigmentation Disorder Treatment Market, 2019 - 2022, USD Million
TABLE 54 Rest of North America Pigmentation Disorder Treatment Market, 2023 - 2030, USD Million
TABLE 55 Rest of North America Pigmentation Disorder Treatment Market, By Type, 2019 - 2022, USD Million
TABLE 56 Rest of North America Pigmentation Disorder Treatment Market, By Type, 2023 - 2030, USD Million
TABLE 57 Rest of North America Pigmentation Disorder Treatment Market, By Treatment, 2019 - 2022, USD Million
TABLE 58 Rest of North America Pigmentation Disorder Treatment Market, By Treatment, 2023 - 2030, USD Million
TABLE 59 Rest of North America Pigmentation Disorder Treatment Market, By Distribution Channel, 2019 - 2022, USD Million
TABLE 60 Rest of North America Pigmentation Disorder Treatment Market, By Distribution Channel, 2023 - 2030, USD Million
TABLE 61 Key Information - Bausch Health Companies Inc
TABLE 62 Key Information - Glenmark Pharmaceuticals Limited
TABLE 63 Key Information - Obagi Cosmeceuticals LLC
TABLE 64 Key Information - AbbVie, Inc.
TABLE 65 Key Information - Dermavant Sciences, Inc.
TABLE 66 Key Information - Incyte Corporation
TABLE 67 Key Information - Dr. Reddy's Laboratories Ltd.
TABLE 68 Key Information - Galderma S.A.
TABLE 69 Key Information - Viatris, Inc.
TABLE 70 Key Information - Pfizer, Inc.

North America Pigmentation Disorder Treatment Market Size, Share & Industry Trends Analysis Report By Type, By Treatment, By Distribution Channel, By Country and Growth Forecast, 2023 - 2030

Description

Table of Contents